Anders I. Persson

University of California, San Francisco — United States

Medicine · Health Sciences

26h-index4.0kcitations112works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(53), Cancer, Hypoxia, and Metabolism(30), Microtubule and mitosis dynamics(15), MicroRNA in disease regulation(14), Neurogenesis and neuroplasticity mechanisms(11)

Publications111 total

Author Correction: Tissue mechanics promote IDH1-dependent HIF1α–tenascin C feedback to regulate glioblastoma aggression
Nature Cell Biology·2023· 5 citedOpen Access
Figure S2 from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Data from Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
2023Open Access
Figure S4 from Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
2023Open Access
Figure S2 from Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
2023Open Access
Figure S6 from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Figure S5 from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Figure S7 from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Figure S7 from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Data from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Data from Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
2023Open Access
Figure S1 from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Figure S2 from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Figure S3 from Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
2023Open Access
Figure S4 from Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
2023Open Access
Figure S3 from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Figure S2 from Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
2023Open Access
Data from Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
2023Open Access
Figure S1 from Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
2023Open Access
Figure S3 from Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
2023Open Access
page 1 of 6Next →

Frequent Co-authors

William A. Weiss(21), Joanna J. Phillips(13), Peter S. Eriksson(12), Thorleif Thorlin(11), Mitchel S. Berger(10), Yekaterina A. Miroshnikova(8), Valerie M. Weaver(8), Shirin Ilkhanizadeh(8), Christin Schmidt(6), Tracy R. McKnight(5), Jasmine Lau(5), C. David James(4), Gabriele Bergers(4), Janna K. Mouw(4), Olle R. Lindberg(4), Fredrik J. Swartling(4), Cecilia Bull(4), Robyn A. Wong(4), Elisabeth Hansson(4), Hanna Sabelström(4)